Mersana Therapeutics Inc (MRSN) is a biotechnology company listed on NASDAQ.
Latest reported MRSN revenue for 2024-12-31 was $40.5M. Net income was -$69.2M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. MRSN currently screens at market cap $145.4M.
Use this MRSN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the MRSN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the MRSN SEC filings page. Lician reads the product cache first so this HTML stays unique to Mersana Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full MRSN income, balance, and cash tables.